Literature DB >> 19536169

miR-34b/miR-34c: a regulator of TCL1 expression in 11q- chronic lymphocytic leukaemia?

B Cardinaud, C Moreilhon, B Marcet, K Robbe-Sermesant, K LeBrigand, B Mari, V Eclache, F Cymbalista, S Raynaud, P Barbry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19536169     DOI： 10.1038/leu.2009.125

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.

Authors:  E Vasyutina; J M Boucas; J Bloehdorn; C Aszyk; G Crispatzu; M Stiefelhagen; A Breuer; P Mayer; C Lengerke; H Döhner; D Beutner; A Rosenwald; S Stilgenbauer; M Hallek; A Benner; M Herling
Journal:  Leukemia       Date:  2015-05-04       Impact factor: 11.528

2.  CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.

Authors:  A Efanov; N Zanesi; N Nazaryan; U Santanam; A Palamarchuk; C M Croce; Y Pekarsky
Journal:  Leukemia       Date:  2010-04-01       Impact factor: 11.528

3.  TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q.

Authors:  Angela Garding; Nupur Bhattacharya; Sarah Haebe; Frederike Müller; Dieter Weichenhan; Irina Idler; Katja Ickstadt; Stephan Stilgenbauer; Daniel Mertens
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

4.  Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway.

Authors:  Brice Marcet; Benoît Chevalier; Guillaume Luxardi; Christelle Coraux; Laure-Emmanuelle Zaragosi; Marie Cibois; Karine Robbe-Sermesant; Thomas Jolly; Bruno Cardinaud; Chimène Moreilhon; Lisa Giovannini-Chami; Béatrice Nawrocki-Raby; Philippe Birembaut; Rainer Waldmann; Laurent Kodjabachian; Pascal Barbry
Journal:  Nat Cell Biol       Date:  2011-05-22       Impact factor: 28.824

5.  Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p.

Authors:  Xiaojian Xu; Shumin Wang; Juan Liu; Dou Dou; Limei Liu; Zhengju Chen; Liping Ye; Huixia Liu; Qiong He; J Usha Raj; Yuansheng Gao
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

Review 6.  Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes.

Authors:  George A Calin; Carlo M Croce
Journal:  Blood       Date:  2009-09-10       Impact factor: 22.113

7.  "Seed-Milarity" confers to hsa-miR-210 and hsa-miR-147b similar functional activity.

Authors:  Thomas Bertero; Sébastien Grosso; Karine Robbe-Sermesant; Kevin Lebrigand; Imene-Sarah Hénaoui; Marie-Pierre Puisségur; Sandra Fourre; Laure-Emmanuelle Zaragosi; Nathalie M Mazure; Gilles Ponzio; Bruno Cardinaud; Pascal Barbry; Roger Rezzonico; Bernard Mari
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 8.  MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune.

Authors:  Alessandro Fatica; Francesco Fazi
Journal:  Int J Mol Sci       Date:  2013-10-18       Impact factor: 5.923

9.  Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.

Authors:  Lu Qian Wang; Yok Lam Kwong; Kit Fai Wong; Chi Shan Bonnie Kho; Dong Yan Jin; Eric Tse; Anders Rosèn; Chor Sang Chim
Journal:  J Transl Med       Date:  2014-02-22       Impact factor: 5.531

10.  miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.

Authors:  Ryuji Morizane; Shizuka Fujii; Toshiaki Monkawa; Ken Hiratsuka; Shintaro Yamaguchi; Koichiro Homma; Hiroshi Itoh
Journal:  Sci Rep       Date:  2014-04-03       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.